In spite of being shown to have anti SARS cov2 virus only in vitro rather than in vivo so far this drug has more probability of working than the antimalarial drug touted by Trump. You probably have open access to the rest of the paper if you would like to judge for yourself.
Available online 3 April 2020, 104787
The FDA-approved Drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro
Highlights
•
Ivermectin is an inhibitor of the COVID-19 causative virus (SARS-CoV-2) in vitro.
•
A single treatment able to effect ∼5000-fold reduction in virus at 48h in cell culture.
•
Ivermectin is FDA-approved for parasitic infections, and therefore has a potential for repurposing.
•
Ivermectin is widely available, due to its inclusion on the WHO model list of essential medicines.